Beta-secretase inhibitors and methods of use

Details for Australian Patent Application No. 2002359301 (hide)

International Classifications

Event Publications

3 April 2003 Complete Application Filed

Priority application(s): 60/397,557 19.07.02 US; 60/348,464 14.01.02 US; 60/397,619 19.07.02 US; 60/335,952 23.10.01 US; 60/348,615 14.01.02 US; 60/333,545 27.11.01 US; 60/390,804 20.06.02 US

24 July 2003 Application Open to Public Inspection

Published as AU-B-2002359301

24 March 2005 Amendment Made

The nature of the amendment is: Add the co-inventor Devasamudram, Thippeswamy 2003

19 April 2007 Change of Name(s) of Applicant(s), Section 104

Zapaq, Inc.; Oklahoma Medical Research Foundation; The Board of Trustees of the University of Illinois The name of the applicant has been changed to Oklahoma Medical Research Foundation; The Board of Trustees of the University of Illinois; CoMentis, Inc.

3 July 2008 Application Accepted

Published as AU-B-2002359301

30 October 2008 Standard Patent Sealed

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.